| Palm Coast Eye Center, P.a. | |
|
3131 S Tamiami Trl, Suite 201, Sarasota, FL 34239-5101 | |
| (941) 954-2020 | |
| (941) 953-3937 |
| Full Name | Palm Coast Eye Center, P.a. |
|---|---|
| Type | Facility |
| Speciality | Ophthalmology |
| Location | 3131 S Tamiami Trl, Sarasota, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053365056 | NPI | - | NPPES |
| CJ5917 | Other | FL | RAILROAD MEDICARE GROUP |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OPC3917 (Florida) | Secondary |
| 207W00000X | Ophthalmology | ME0045451 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Palm Coast Eye Center, P.a. 5601 21st Ave W, Bradenton, FL 34209-5642 Ph: (941) 794-2020 | Palm Coast Eye Center, P.a. 3131 S Tamiami Trl, Suite 201, Sarasota, FL 34239-5101 Ph: (941) 954-2020 |
News Archive
As president of the G8 in 2010, "Canada will champion a new G8 identity focused on ending child mortality and other health woes in poorer countries when it hosts the club of industrialized nations in June, the government said Tuesday," Agence France-Presse reports. A spokesman for Canadian Prime Minister Stephen Harper explained Tuesday that Harper will use his keynote address at the World Economic Forum annual meeting in Davos, Switzerland, to provide more details about the new G8 agenda, according to AFP (1/26).
About 50,000 of the 4.7 million Medicare beneficiaries who opted to have their Medicare prescription drug benefit premiums automatically withdrawn from their Social Security checks still are having incorrect amounts deducted, CMS officials said, USA Today reports.
Cell Therapeutics, Inc. today announced that it has been awarded $977,917 in grants under the Therapeutic Discovery Tax Credit program that was enacted under the U.S. government's Patient Protection and Affordable Care Act. The program targets projects that show potential to produce new therapies, address unmet medical needs, reduce the long-term growth of health care costs and advance the goal of curing cancer.
Diabetes is growing at an alarming rate in Canada, with an estimated 3.7 million people expected to be diagnosed by 2020. It is a progressive disease that, if not properly monitored and managed over time, will lead to serious long term complications. Canadians now have a novel treatment available to help them maintain optimal blood glucose levels. Health Canada has approved Victoza (liraglutide), the first GLP-1 analogue, for once-daily administration for the treatment of adults with type 2 diabetes to improve glycemic control in combination with metformin or metformin and a sulfonylurea.
New research has uncovered a link between being married and living longer among cancer patients, with the beneficial effect of marriage differing by race/ethnicity and place of birth. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings have important public health implications, given the rising numbers of unmarried individuals in the United States in addition to the growing aging population.
› Verified 9 days ago